oral glp-1 agonist approved GLP-1: A Needle-Free Solution for Weight Loss GLP-1 Agonists: A Comprehensive Overview

34 The FOCUS Trial should shed light on how many patients treated with GLP-1/GIP agonists experience significant worsening of their DR and macular edema

10.1210/jc.2011-1074 88 MerchenthalerI.LaneM.ShughrueP

10.3389/fphar.2024.1416985

A study published last summer by JAMA Oncology looked at GLP-1 use and 14 obesity-related cancers and found that while the weight-loss drug lowered the risk of most cancers, there was a nonsignificant increased risk of kidney cancer particularly among people younger than 65

These medications mimic the hormone Glucagon-like Peptide 1 (GLP-1) which helps the pancreas release insulin in response to meals, safely lowering blood sugars

Funding This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: NRF-2019R1F1A1054111 (JS), NRF-2019R1I1A3A01058861 (OK), and NRF-2018R1A2B6001104 (Y-KK)